We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current ACTU market cap is 168.17M. The company's latest EPS is USD -1.2669 and P/E is -6.99.
Quarter End | Mar 2024 | Jun 2024 |
---|---|---|
USD (US$) | ||
Total Revenue | 0 | 0 |
Operating Income | -7.77M | -5.44M |
Net Income | -8.3M | -6.57M |
Year End 31 December 2023 | 2023 |
---|---|
USD (US$) | |
Total Revenue | 0 |
Operating Income | -24.97M |
Net Income | -24.75M |
Quarter End | Mar 2024 | Jun 2024 |
---|---|---|
USD (US$) | ||
Total Assets | 2.7M | 1.73M |
Total Liabilities | 16.3M | 21.81M |
Total Equity | -107.77M | -114.26M |
Year End 31 December 2023 | 2023 |
---|---|
USD (US$) | |
Total Assets | 3M |
Total Liabilities | 8.44M |
Total Equity | -99.63M |
Market Cap | 168.17M |
Price to Earnings Ratio | -6.99 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 58.48 |
Price to Book Ratio | -31.76 |
Dividend Yield | - |
Shares Outstanding | 19.53M |
Average Volume (1 week) | 51.24k |
Average Volume (1 Month) | 56.04k |
52 Week Change | 72.20% |
52 Week High | 10.162 |
52 Week Low | 5.00 |
Spread (Intraday) | 0.29 (3.29%) |
Company Name | Actuate Therapeutics Inc |
Address |
108 lakeland ave dover, delaware 19901 |
Website | https://www.actuatetherapeutics.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions